[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$oncs
$ONCS sees a surge in engagements, fueled by positive community sentiment. Analysts predict durable growth for $ONCS with upcoming data readouts.
About $oncs
A cryptocurrency.
Insights #
- $oncs engagements is up XXXXXXXX% from the previous week.
Engagements: X #
Engagements 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XXX
1 Week: XXX +1,756%
1 Month: XXX -XX%
1-Year High: XXXXX on 2025-08-11
1-Year Low: X on 2025-05-04
| Social Network | X |
|---|---|
| Engagements | X |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: XX on 2025-08-12
1-Year Low: X on 2025-05-01
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $oncs in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-07-18
1-Year Low: X on 2025-05-01
Top assets mentioned In the posts about $oncs in the last XX hours
One Cash (ONC) Alnylam Pharmaceuticals, Inc. (ALNY)
Top topics mentioned In the posts about $oncs in the last XX hours
$onc, coins stablecoin, $barcl, positions, $cvac, $bntx, stocks healthcare, alnylam pharmaceuticals inc
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ONCS $CVAC $BNTX $ALNY $EBS $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $PDSB $TFX $GOVX $IGC $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX $GME $AMC $BTC $jd $baba $anf $nvda $mstr"
X Link @edward_petez 2025-10-10T18:38Z 1134 followers, XXX engagements
"Barclays🏁 $ONC Overweight-$385 and said BeOne (ONC) is a commercial oncology company developing therapies across hematologic and solid tumors. $ONC's broad oncology pipeline positions it for durable growth. Barclay additionally said: We initiate coverage of BeOne (ONC) with an Overweight rating and $XXX PT ahead of two value-inflecting pivotal data readouts; 1) Data for BTK inhibitor in first line mantle cell lymphoma in 2H25; and 2) Data in first line gastroesophageal cancer for PD1 inhibitor + anti-HER2 combination in 4Q25"
X Link @Quantumup1 2025-09-18T12:23Z 3834 followers, 1376 engagements